Jynarque 60 MG
Ended Awarded
- Contract number
- 36C24521F0385
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,299
Award facts
- Contract value 100% obligated
- $10,298.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Deerfield, IL 60015, USA
Award details come from SAM.gov/FPDS.
About this award
On May 25, 2021, the Department of Veterans Affairs' Veterans Integrated Service Network 5 (VISN 5) awarded a delivery order to Otsuka America Pharmaceutical Inc. for Jynarque 60 mg, a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. The contract, valued at $10,298.57, was issued on a firm fixed-price basis with no set-aside designation and was completed by May 28, 2021. This delivery order was issued under Otsuka America Pharmaceutical Inc.'s larger Blanket Purchase Agreement for Jynarque valued at $83.3 million, which was awarded by the VA's National Acquisition Center under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and extends through March 26, 2026.
Otsuka America Pharmaceutical Inc., headquartered in Rockville, Maryland, is a for-profit pharmaceutical manufacturer specializing in complex medical treatments with an established track record as a federal contractor to the VA. The company has been awarded multiple delivery orders across several VA Integrated Service Networks for various Jynarque dosages and maintains a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology products. The performance location for this delivery order was Riverwoods, Illinois, supporting the VA's mission to provide specialized pharmaceutical treatments to veterans nationwide.
Quick answers
Who was awarded contract 36C24521F0385?
36C24521F0385 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on May 25, 2021.
How much is contract 36C24521F0385 worth?
The government has obligated $10,299 on 36C24521F0385.
Is contract 36C24521F0385 an order under another contract?
Yes. 36C24521F0385 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24521F0385 competed?
The extent of competition for 36C24521F0385 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award